Updates shares in paragraph 2, adds background from paragraph 5 onward
Feb 21 (Reuters) - The U.S. Justice Department has launched an investigation into UnitedHealth's UNH.N Medicare billing practices in recent months, the Wall Street Journal reported on Friday, citing people familiar with the matter.
Shares of the company fell nearly 10% in premarket trading. Shares of other health insurers also fell before the bell.
The new civil fraud investigation is examining UnitedHealth's practices for recording diagnoses that trigger extra payments to its Medicare Advantage plans, including at physician groups the insurance giant owns, the report added.
DoJ and UnitedHealth did not immediately respond to Reuters requests for comment.
Medicare Advantage plans are offered by private insurers who are paid a set rate by the U.S. government to manage healthcare for older people looking for extra benefits not covered in the regular Medicare coverage. The DoJ has a long-running lawsuit pending against UnitedHealth over Medicare Advantage.
The department had also sued to block UnitedHealth's $3.3 billion acquisition of Amedisys Inc AMED.O, citing concerns that the deal would reduce competition in the home health services market.
UnitedHealth runs the country's largest health insurer, UnitedHealthcare, as well as pharmacy benefit manager Optum and medical practices.
The company and its peers, who provide government-backed Medicare and Medicaid insurance plans for low-income individuals, have seen an increase in medical costs over the last few quarters.
The company also encountered other challenges last year, including a cyberattack on its tech division Change Healthcare and a backlash over denial of insurance claims after the murder of UnitedHealthcare CEO Brian Thompson.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)
((Sriparna.Roy@thomsonreuters.com;))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。